info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
United States Flag  US: +1-315-636-4233    United Kingdom Flag  UK: +44-162-237-0614    Indian Flag  IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
Home » Press Releases » Contrast Media Injectors' global market share will be worth 2.67 billion U.S. dollars by 2030.

Contrast Media Injectors' global market share will be worth 2.67 billion U.S. dollars by 2030.


Published Date: Apr-2022 | Report Format:Electronic (PDF)

The report " Contrast Media Injectors Market" markets is segmented By end-user (hospitals and Diagnostic Imaging Centers), By Product (injector systems, consumables, and accessories), By Application (radiology, interventional radiology, and interventional cardiology), By Region (North America, the Asia Pacific, Europe, and the Rest of the World) – Global forecast to 2030. By 2030, the Contrast Media Injectors Market size will reach 2.67 billion U.S. dollars with a significant growing CAGR of 7.5%. 

Technological advancements, an increasing number of regulatory approvals, and increasing demand for minimally invasive surgeries are the significant factors constituting the growth of the contrast media injectors market. Many significant advanced features have been introduced in contrast media injector technology to automate the overall data collection process regarding the dose received by a patient.  

 

To know more about the report, Click on the link :-  https://www.strategicmarketresearch.com/market-report/contrast-media-injectors-market

 

KEY FACTORS AUGMENTING THE MARKET GROWTH

According to WHO (World health organization) reports, it is estimated that approximately 17.7 million people died of CVDs in 2015, which is equivalent to 31% of total deaths in 2015 globally. Furthermore, it is forecasted that by 2030 the number of fatalities will reach 23.6 million. Thus, the increasing number of CVD and cancer cases, in turn, increases the need for contrast media injectors thus, expanding the overall market size of global contrast media injectors. 

 

By Product " consumables " segment held the highest share in 2020 

Injector systems, consumables, and accessories are the segments into which the global contrast media injectors market is divided based on Product. Consumables are currently enjoying the largest market share with a steady CAGR among the three. Consumables are mostly used for safety and hygiene procedures, thus increasing the need for consumables.

 

By Application " Radiology " segment held the highest share in 2020 

Radiology, interventional radiology, and interventional cardiology are the segments into which the global contrast media injectors market is divided based on Product. The Radiology segment is currently enjoying the largest market share with a decent CAGR among the three. 

 

By end-user "Hospitals" segment held the highest share in 2020 

Hospitals and diagnostic imaging centers are the segments into which the global contrast media injectors market is divided based on end-users. The hospital segment is enjoying the largest market share with a growing CAGR, followed by diagnostic imaging centers. The increase in the growth of revenues of diagnostic centers is due to the non-availability of advanced screening facilities in mid and medium cap hospitals.

 

By region "North America" segment held the highest share in 2020

In the United States, according to the reports suggested by the Centers for Disease Control and Prevention 2021, the main reason for the deaths is due to chronic diseases such as diabetes, heart disease, and cancer, contributing to annual health care costs of 3.8 trillion U.S. dollars. It is also reported that 6 in every ten individuals are suffering from chronic disease, and 4 in every ten individuals are suffering from 2 or more chronic conditions. In addition to this, according to Heart Disease & Stroke Statistical Fact Sheet 2020, every year, at least 40,000 infants suffer in the USA due to congenital heart defects. Thus, the prevalence of these diseases and technological advancements in North America are the driving factors for the enormous market share. 

 

Recent Developments  

  • In December 2021, to develop Gadopiclenol, a high-relaxivity, macrocyclic contrast agent. a strategic collaboration was announced by Braco Imaging with Guerbet. 
  • In December 2021, Qaelum NV and Ulrich GmbH & Co. K.G. in Ulm announced that they would be partnering to combine their services to improve the functioning and support provided to hospitals. With the help of collaboration, both organizations are trying to connect the contrast media injectors of Ulrich medical with a Contrast Management solution.
  • In May 2020, a version of German medical technology company, C.T. motion contrast media injector, was developed for the American market at the RSNA in Chicago. In collaboration with G.E. Healthcare, this Product was approved by FDA.

Choose License Type



$0
$0
$0
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: (+1) 315-636-4233
  • UK: (+44) 1622-370-614
  • IN: (+91) 826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved